Toxicity Assessment of CAR-T Cells
"On-target/off-tumor" toxicity was an expected side effect of CAR T therapy from the outset. In Situ Hybridization (ISH) is a great method that can be utilized to identify novel CAR-T cell targets and subsequently qualify monoclonal antibodies directed against those targets for immunohistochemistry. ISH can be used to predict CAR-T cell target organ toxicity in preclinical models.
Disrtribution Assessment of CAR-T CellsStatistics: Posted by hannahcole — Thu Oct 24, 2024 10:35 am
]]>